
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Bellerophon Therapeutics operates in the Biotechnology Research industry and is headquartered in United States.
Bellerophon Therapeutics has approximately 11-50 employees employees.
Bellerophon Therapeutics is based in Warren, New Jersey, United States.
Yes. Bellerophon Therapeutics is a publicly traded company.
You can reach Bellerophon Therapeutics’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.
Our team will be in touch soon. If you have any questions, please email us at info@scalelist.com
Just a few more details..
Our team will be in touch soon. If you have any questions, please email us at arnaud@scalelist.com